The company is now offering its GI SereniT analysis test as part of its Floré Clinical program.
Personalized-probiotic product brand Floré is now offering consumers an at-home stool-analysis test to better match a probiotic intervention with a consumer’s need. The company is now offering its GI SereniT analysis test as part of its Floré Clinical program.
The Floré Clinical program matches consumers with a corresponding supplementation regimen targeting microbiome health. The new GI SereniT test provides more personalized data on a consumer’s microbiome status.
“Patients can easily administer the at-home stool collection and be provided with an assessment of their microbiome in five key areas: wellness assessment and health scores, microbiome diversity, disease association, ‘How You Compare,’ and ‘Identification of Organisms,’” the company’s press release states. It adds: “Providers can then refer them to a 3-month, 6-month, or 12-month Floré customized probiotic/prebiotic program based on their results.”
The company calls GI SereniT “the leader in the next generation of comprehensive stool analysis via whole genome sequencing (WGS) of the human gut microbiome.” It is said to provide “clinically relevant insights” on gut dysbiosis, microbiome diversity, pathogenic bacteria, irritable bowel syndrome, irritable bowel disease, and other measures. “It can identify and detect over 100,000 genomes and 25,000 specimens of organisms while revealing important information about gastrointestinal symptoms that many people suffer from, such as gas, bloating, stomach pain, and constipation,” it concludes.